BACKGROUND High-output heart failure (HF) is an unusual cause of cardiac failure that has not been well-characterized.
hypertension by direct invasive assessment.
High-output HF cases were adjudicated using the Framingham criteria to confirm the diagnosis (Online Table 1 Control subjects free of HF enrolled in a separate prospective study were included as the comparator population (5, 6) . Control subjects displayed no evidence of cardiac pathology after detailed noninvasive and invasive assessment, including history, physical, imaging, and normal rest and exercise pulmonary wedge pressures and mean pulmonary artery pressures (5, 6) . INVASIVE HEMODYNAMIC ASSESSMENT. Subjects were studied on their chronic medications in the fasted state and supine position after minimal sedation, as described previously (5) (6) (7) . Pressures in the right atrium, pulmonary artery, and pulmonary capillary wedge position were measured at end-expiration from electronically stored continuous recordings of pressure tracings digitized at 240 Hz. Systemic and mixed venous oxygen contents were determined by blood sampling (¼ saturation Â hemoglobin Â 1.34) to determine the arterial-venous oxygen content difference. Cardiac output was determined by the direct Fick method (oxygen consumption/[arterial-venous oxygen difference]) (n ¼ 53) or by thermodilution (n ¼ 91).
Oxygen consumption was measured directly by expired gas analysis (MedGraphics, St. Paul, Minnesota), or calculated indirectly by multiplying the thermodilution cardiac output by the directly measured arterial-venous oxygen content difference according to the Fick principle.
Stroke volume was calculated as cardiac output divided by heart rate. Systemic vascular resistance was calculated from the pressure drop across the systemic circulations (mean arterial pressure-right atrial pressure) multiplied by 80, divided by cardiac output (5) (6) (7) . Plasma volume at the time of catheterization was estimated by: Linear regression was used to determine the correlation between continuous variables of interest. All tests were 2-sided, with a p value <0.05 considered significant. Analyses were performed using JMP version 10.0.0 (SAS Institute, Cary, North Carolina). 
RESULTS
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A U G U S T 2 , 2 0 1 6 : 4 7 3 -8 2 mass index, more natriuretic peptide activation, greater estimated plasma volume, and a higher likelihood of being treated with diuretic agents ( Table 1) .
Age, sex, comorbid conditions, and body surface area were similar in high-output HF cases and controls.
Most of the high-output patients presented with left-sided HF (n ¼ 91, 76%), although a minority presented with right HF (n ¼ 29, 24%). The clinical, echocardiographic, and hemodynamic differences between left-and right-sided high-output HF are provided in Online Lung diseaseÀassociated high-output HF (n ¼ 19, 16%) included patients with chronic obstructive pulmonary disease (n ¼ 7), connective tissue disorders (n ¼ 5), bronchiolitis obliterans (n ¼ 1), interstitial lung disease (n ¼ 5), and bronchiectasis (n ¼ 1).
Hematologic disorders were the only identifiable cause in 8% of cases (n ¼ 10). Each of these were myeloproliferative disorders characterized by hepatosplenomegaly and extramedullary hematopoiesis, including primary and secondary myelofibrosis (n ¼ 8), and chronic myelomonocytic leukemia (n ¼ 2).
CHARACTERISTICS OF HIGH-OUTPUT HF ETIOLOGIES.
Most hemodynamic and ventricular function findings were fairly uniform among the different etiologies of high-output HF, although there were some notable differences ( Table 2) . Obesity and liver-associated patients had greater body size, weight, and higher estimated plasma volume. The hematologic and liver diseaseÀassociated high-output HF groups had marginally lower hemoglobin levels than the remaining groups. As expected, the shunt group had worse renal function, given that 67% had arteriovenous fistulas for the purpose of hemodialysis access. Absolute oxygen consumption was highest in obesity-related high-output HF, but this was explained solely by greater body mass, as the difference was eliminated after adjustment for weight ( Reddy et al. (Figure 2) , and by the greater Survival Time (Years) High-Output Heart Failure mortality observed in patients with the greatest reduction in systemic vascular resistance ( Figure 3C) .
The fluid retention and congestion in patients with high-output failure is similar to what has previously been described in elegant pathophysiologic studies of low-output HF (10) and severe anemia (11) .
Further study is needed to determine whether interventions to mitigate excessive vasodilation may be effective in treating the various forms of highoutput failure. SPECIFIC ETIOLOGIES. Traditionally described causes of high-output HF, such as thiamine deficiency (beriberi) and Paget's disease were not observed in this series, and only 1 case of thyrotoxicosis was identified (not included in the analysis according to study design). We also excluded patients with severe anemia, as this is a well-described and more easily reversible cause of high-outputÀrelated congestion (11) . Although this may, in part, be related to the referral bias of a cardiac catheterization laboratory population, it appears that in the modern era, obesity, cirrhosis, and arteriovenous shunts may be the most common causes of this form of HF.
OBESITY-RELATED HIGH-OUTPUT HF. Two-thirds of American adults are currently overweight or obese, and the prevalence is growing (12). As such, the problem of obesity-related heart diseases will only be expected to increase in the coming years (13) . Obesity was the most common cause of high-output HF in this contemporary series. Reductions in arterial resistance are well-described in obesity (13) (14) (15) , caused by increased capillary perfusion to adipose tissue and elaboration in fat cells of vasoactive adipokines (16).
The resultant renal hypoperfusion caused by low vascular resistance is believed to promote sodium retention and increase cardiac work (1) (2) (3) . Total body oxygen consumption was increased in obesity, but this was driven largely by higher total body mass, in comparison to the other etiologies of highoutput HF.
In addition to peripheral effects on vascular resistance and metabolism, obesity affects the heart directly. Left ventricular efficiency is 50% lower when the heart utilizes fatty acids as opposed to glucose as its primary substrate (17) . In obese women without HF, myocardial oxygen consumption, fatty acid uptake, and stroke work vary directly with body mass, whereas ventricular efficiency varies inversely with body mass (18 Patients in the high-output group displayed an elevated E/e' ratio (often used as a noninvasive measure of diastolic dysfunction) and normal EF, suggesting that many of these patients might have been erroneously diagnosed as having HF with preserved EF (HFpEF) if there had been no direct assessment of cardiac output. This observation emphasizes the importance of considering highoutput HF in the differential diagnosis. There is increasing evidence that patients with HFpEF are a heterogeneous group comprising many phenotypes (25) . The current data show that high-output HF must also be considered in the differential diagnosis, and probably should be categorized separately from more garden-variety patients with HFpEF. The current data show that the presence of an increased echocardiographic Doppler-derived cardiac index >3.5 l/min/m 2 should prompt clinicians to consider further evaluation to clarify the diagnosis. STUDY LIMITATIONS. This study was performed in a catheterization laboratory referral population, thus some causes of high-output HF might have been underrepresented if patients were less likely to be referred for invasive study. Data were not acquired prospectively, but from chart review. Very few patients received specific treatments directed toward high-output HF, other than diuretic agents, so we cannot make any conclusions regarding treatment from these data. Cause of death was not available.
Oxygen consumption was not directly measured in all subjects, but rather solved for by using the Fick equation in patients where thermodilution outputs were obtained.
CONCLUSIONS
High-output HF is an important cause of cardiac failure that is associated with increased mortality.
Despite the wide variety of underlying etiologies, the causes share a common pathophysiology of excessively depressed arterial resistance and heightened metabolic demand that causes congestion, despite a hyperdynamic circulation. Given the high mortality in high-output HF, and the increasing prevalence of obesity and liver and kidney disease worldwide, this disease must be considered in the differential diagnosis of patients presenting with clinical HF in the setting of a normal EF. High-Output Heart Failure
